Clinical Trial Search
To find a clinical trial, use our search tool below. You can find a clinical trial by disease, drug, or doctor.
Learn more about clinical trials before you decide to join:
Additional resources:
- Taking Part in a Cancer Clinical Trial (For Patients)
- Clinical Trials Education Resources (For Clinicians)
Contact Us
Ask CLARA the Virtual Assistant
General Information
Cancer Learning Center
1-888-424-2100
Business Operations
Clinical Trials Office
801-646-9922
HCI-Clinicaltrials@hci.utah.edu
Search Tool
Search Clinical Trials
Showing 1–25 of 333 results
- (Only open at Grand Valley Oncology) The CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer): CompassHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib
- 165-501: A Multi-Center, Observational Study to Evaluate the Long-Term Safety of Subcutaneous Injections of Palynziq® (pegvaliase) in Subjects with Phenylketonuria
- ACTION-JIA: Advancing Consensus Treatment to Improve Outcomes Now
- A First-in-Human Phase 1 Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KST-6051 in Patients With Advanced or Metastatic Solid Tumors With a KRAS Mutation
- A First-in-Human Study of Mutant-Selective PI3Ka Inhibitor, RLY-2608, as a Single Agent in Advanced Solid Tumor Patients and in Combination With Fulvestrant in Patients With Advanced Breast Cancer
- A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma The MOAB Trial
- An Early Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of PEEL-224 in Patients with Advanced Solid Tumors
- An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer MODERN
- An Interventional, Open-Label, Randomized, Multicenter, Phase 3 Study of PF-07248144 Plus Fulvestrant Compared to Investigator?s Choice of Therapy in Adult Participants with Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Whose Disease Progressed After Prior CDK4/6 Inhibitor-Based Therapy
- An Interventional Phase 3, Double-blind, Randomized Study to Evaluate Efficacy and Safety of PF-08634404 in Combination with Chemotherapy versus Pembrolizumab in Combination with Chemotherapy in Adult Participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- An Open-label, Multicenter Study of LOXO-435 (LY3866288) in Advanced Solid Tumor Malignancies with FGFR3 Alterations
- An Open-Label, Phase I/Ib, Study of ORIC-944 in Patients with Metastatic Prostate Cancer
- An Open-Label Multi-Cohort Phase IB/II Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Budigalimab in Advanced or Metastatic Non-Squamous NSCLC with No Prior Treatment for Advanced Disease and No Actionable Genomic Alterations (AndroMETa-Lung-536)
- Anterior versus Posterior Surgery for Isthmic Spondylolisthesis (I-Spondy)
- A Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants with Chronic Myeloid Leukemia
- A Phase 1 Study of the Polymerase Theta (POL?) Inhibitor Novobiocin in BRCA-mutant and Other DNA Damage Repair-Deficient Solid Tumors
- A Phase 1, 2-Part, Multicenter, First-In-Human Dose-Escalation and Dose-Expansion Study Of DS-1103A Combination Therapy In Subjects with Advanced Solid Tumors
- A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients who are BCG Naïve or Received Incomplete BCG Treatment
- A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-tumor Activity of TNG462 in Patients with MTAP-deleted Advanced or Metastatic Solid Tumors
- A Phase 1/2, Multicenter, Open-label, Non- randomized Study to Investigate Safety and Tolerability, Pharmacokinetics, Dosimetry, and Preliminary Activity of 177Lu Lu-FAP-2286 in Participants with an Advanced Solid Tumor
- A Phase 1/2, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of TNG456 Monotherapy and in Combination with Abemaciclib in Patients with Solid Tumors with MTAP Loss
- A Phase 1/2, Open-Label, Dose-Escalation, Dose-Expansion Study of DSP-5336 in Adult Patients with Acute Leukemia and Other Selected Hematologic Malignancies, with and without Mixed Lineage Leukemia (MLL) rearrangement or Nucleophosmin 1 (NPM1) Mutation
- A Phase 1/2, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-3654 in Patients with Intermediate or High-risk Primary or Secondary Myelofibrosis
- A Phase 1/2a, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of JAB-23E73 in Adult Patients with Advanced Solid Tumors with KRAS Alteration
Phases of Clinical Trials
If you’re considering joining a clinical trial, you may want to learn about the different phases of clinical trials. Depending on your interests and treatment goals, you may want to join a clinical trial that’s in a particular phase.
There are four phases of clinical trials for testing cancer drugs and treatments:
Phase 1
- Tests a new drug for the first time in humans
- Shows how much of the new drug is safe and how often doctors should give it
- Shows what side effects patients can expect
- Includes a small number of patients
Phase 2
- Builds on data collected in Phase 1
- Tests how well a drug works on a specific kind and stage of cancer
- Includes a small number of patients
Phase 3
- Tests drugs that researchers think will be effective based on results of Phase 2
- Compares new and standard treatments
- Usually, researchers must randomly assign patients to get the new or standard treatment
- Can include hundreds or thousands of patients
Phase 4
- Evaluates the long-term safety and effectiveness of the treatment
- These studies usually take place after the treatment has been approved for standard use
- Several hundred to several thousand people may participate
Other Types of Clinical Trials
In addition to the four phases for standard cancer trials, there are other types of clinical trials:
Quality-of-Life Trials
Quality-of-life (also called supportive care) trials explore ways to improve comfort and quality of life for cancer patients and survivors. These trials may study ways to help people who are experiencing symptoms like nausea, sleep disorders, or other effects from cancer and treatment.
Genetic Studies
Genetic studies are sometimes part of another cancer clinical trial. The genetic part of a trial may focus on how genetics can affect how a patient responds to cancer treatment, or if genetics play a role in making a patient more likely to get cancer or have certain side effects.
Provider Clinical Trial Search
Helping Doctors Find Clinical Trials for Their Patients
Are you a doctor looking for a clinical trial to enroll your patient in?
This mobile-friendly search tool is specially designed to be used on your smartphone or tablet device. You can save this link to your smartphone screen and use it like an app:
As a physician, you can use this tool to find clinical trials that may be appropriate for your patients, including trials available at Huntsman Cancer Institute's community clinics.
